Literature DB >> 19498374

Expansion and contraction: treating diabetes with bariatric surgery.

Allison B Goldfine1, Steven E Shoelson, Vincent Aguirre.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19498374     DOI： 10.1038/nm0609-616

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery.

Authors:  Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel
Journal:  N Engl J Med       Date:  2004-12-23       Impact factor: 91.245

2.  Long-term mortality after gastric bypass surgery.

Authors:  Ted D Adams; Richard E Gress; Sherman C Smith; R Chad Halverson; Steven C Simper; Wayne D Rosamond; Michael J Lamonte; Antoinette M Stroup; Steven C Hunt
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

3.  First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve.

Authors:  Leonardo Rodriguez-Grunert; Manoel Passos Galvao Neto; Munir Alamo; Almino Cardoso Ramos; Percy Brante Baez; Michael Tarnoff
Journal:  Surg Obes Relat Dis       Date:  2008 Jan-Feb       Impact factor: 4.734

4.  An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity.

Authors:  Vincent Aguirre; Nicholas Stylopoulos; Ronit Grinbaum; Lee M Kaplan
Journal:  Obesity (Silver Spring)       Date:  2008-10-30       Impact factor: 5.002

5.  Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial.

Authors:  John B Dixon; Paul E O'Brien; Julie Playfair; Leon Chapman; Linda M Schachter; Stewart Skinner; Joseph Proietto; Michael Bailey; Margaret Anderson
Journal:  JAMA       Date:  2008-01-23       Impact factor: 56.272

6.  Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects.

Authors:  Rosa Morínigo; Violeta Moizé; Melina Musri; Antonio M Lacy; Salvador Navarro; José Luís Marín; Salvadora Delgado; Roser Casamitjana; Josep Vidal
Journal:  J Clin Endocrinol Metab       Date:  2006-02-14       Impact factor: 5.958

7.  Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus.

Authors:  Philip R Schauer; Bartolome Burguera; Sayeed Ikramuddin; Dan Cottam; William Gourash; Giselle Hamad; George M Eid; Samer Mattar; Ramesh Ramanathan; Emma Barinas-Mitchel; R Harsha Rao; Lewis Kuller; David Kelley
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

8.  Narrative review: effect of bariatric surgery on type 2 diabetes mellitus.

Authors:  Marion L Vetter; Serena Cardillo; Michael R Rickels; Nayyar Iqbal
Journal:  Ann Intern Med       Date:  2009-01-20       Impact factor: 25.391

9.  Effects of bariatric surgery on mortality in Swedish obese subjects.

Authors:  Lars Sjöström; Kristina Narbro; C David Sjöström; Kristjan Karason; Bo Larsson; Hans Wedel; Ted Lystig; Marianne Sullivan; Claude Bouchard; Björn Carlsson; Calle Bengtsson; Sven Dahlgren; Anders Gummesson; Peter Jacobson; Jan Karlsson; Anna-Karin Lindroos; Hans Lönroth; Ingmar Näslund; Torsten Olbers; Kaj Stenlöf; Jarl Torgerson; Göran Agren; Lena M S Carlsson
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

10.  Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety.

Authors:  C M Borg; C W le Roux; M A Ghatei; S R Bloom; A G Patel; S J B Aylwin
Journal:  Br J Surg       Date:  2006-02       Impact factor: 6.939
View more
  17 in total

1.  Mouse Models of Bariatric Surgery.

Authors:  Deng Ping Yin; Kelli L Boyd; Phillip E Williams; Naji N Abumrad; David H Wasserman
Journal:  Curr Protoc Mouse Biol       Date:  2012-12-01

2.  Duodenal-jejunal bypass changes the composition of the gut microbiota.

Authors:  Hideya Kashihara; Mitsuo Shimada; Kozo Yoshikawa; Jun Higashijima; Toshihiro Nakao; Masaaki Nishi; Chie Takasu
Journal:  Surg Today       Date:  2016-07-13       Impact factor: 2.549

3.  Comparison of the effects of Roux-en-Y gastric bypass and ileal transposition surgeries on food intake, body weight, and circulating peptide YY concentrations in rats.

Authors:  Prasanth K Chelikani; Imran H Shah; Esmaeel Taqi; David L Sigalet; Henry H Koopmans
Journal:  Obes Surg       Date:  2010-09       Impact factor: 4.129

4.  Duodenal-Jejunal Bypass Maintains Gut Permeability by Suppressing Gut Inflammation.

Authors:  Hideya Kashihara; Mitsuo Shimada; Kozo Yoshikawa; Jun Higashijima; Tomohiko Miyatani; Takuya Tokunaga; Masaaki Nishi; Chie Takasu
Journal:  Obes Surg       Date:  2019-09       Impact factor: 4.129

5.  Cytokine abnormalities in the etiology of the cardiometabolic syndrome.

Authors:  Vincent G DeMarco; Megan S Johnson; Adam T Whaley-Connell; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2010-04       Impact factor: 5.369

6.  Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass.

Authors:  J C Reubi; A Perren; R Rehmann; B Waser; E Christ; M Callery; A B Goldfine; M E Patti
Journal:  Diabetologia       Date:  2010-09-14       Impact factor: 10.122

7.  Weight loss induced by Roux-en-Y gastric bypass but not laparoscopic adjustable gastric banding increases circulating bile acids.

Authors:  Rohit Kohli; David Bradley; Kenneth D Setchell; J Christopher Eagon; Nada Abumrad; Samuel Klein
Journal:  J Clin Endocrinol Metab       Date:  2013-03-01       Impact factor: 5.958

8.  Endoscopic duodenal-jejunal bypass liner rapidly improves type 2 diabetes.

Authors:  Charlotte de Jonge; Sander S Rensen; Froukje J Verdam; Royce P Vincent; Steve R Bloom; Wim A Buurman; Carel W le Roux; Nicolaas C Schaper; Nicole D Bouvy; Jan Willem M Greve
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

9.  Co-expressed immune and metabolic genes in visceral and subcutaneous adipose tissue from severely obese individuals are associated with plasma HDL and glucose levels: a microarray study.

Authors:  Marcel G M Wolfs; Sander S Rensen; Elinda J Bruin-Van Dijk; Froukje J Verdam; Jan-Willem Greve; Bahram Sanjabi; Marcel Bruinenberg; Cisca Wijmenga; Timon W van Haeften; Wim A Buurman; Lude Franke; Marten H Hofker
Journal:  BMC Med Genomics       Date:  2010-08-05       Impact factor: 3.063

Review 10.  Duodenal-jejunal bypass liner to treat type 2 diabetes mellitus in morbidly obese patients.

Authors:  Rodrigo Muñoz; Alex Escalona
Journal:  Curr Cardiol Rep       Date:  2014-03       Impact factor: 2.931
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.